Conclusion
Based on our long term follow-up results, the Ophira SIS had similar
cure rates to the trans-obturator MUS among women undergoing surgery for
SUI. This is the first study assessing long-term outcomes following
randomization to a SIS and standard MUS treatment. However, results
obtained with one SIS cannot be applied to another, so external
validation studies, therefore, are also needed. We believe our results
should be included in future meta-analyses to foster better
understanding of the role of SIS systems in SUI management.